INS and cancer: The present observational study, which is a part of the Cancer Risk and Insulin Analogues (CARING) project, sought to investigate the effect of exposure to insulin glargine or insulin detemir on cancer risk as compared with that of human insulin, mitigating through study design and analytical approaches the limitations and biases involved in the previous studies.